Collard Craig A
SEC CIK 1363558 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | CEO, Dir | 856.5K | $138.0K | — | 22 | 2023-05-22 | 2026-07-30 |
Most active insiders at HRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cusack Thomas | Dir | — | — |
| 2 | Hensley Mark Earl | COO | — | — |
| 3 | Morgan Adam | Dir | — | — |
| 4 | Rosen David Efraim | 10% | — | — |
| 5 | Dissanaike Sharmila | Dir | — | — |
| 6 | Kaseta Michael | Dir | — | — |
| 7 | Christian Waage | Dir | — | — |
| 8 | Duarte Ira | EVP, CFO | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Collard Craig A | CEO, Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-03 09:32 | 2026-07-30+ | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +84.8K | 856.5K | +11% | — |
| D | 2026-07-20 16:22 | 2026-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +13.8K | 771.7K | +2% | — |
| DM | 2026-05-04 11:30 | 2026-04-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +84.8K | 757.9K | +13% | — |
| D | 2026-04-21 09:41 | 2026-04-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +13.8K | 662.1K | +2% | — |
| D | 2026-04-06 19:06 | 2026-04-03 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +62.5K | 648.3K | +11% | — |
| D | 2026-02-03 | 2026-01-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +34.8K | 571.7K | +6% | — |
| D | 2026-01-20 | 2026-01-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +13.8K | 536.9K | +3% | — |
| D | 2025-11-04 | 2025-10-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +34.8K | 523.1K | +7% | — |
| D | 2025-10-21 | 2025-10-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +13.8K | 488.3K | +3% | — |
| D | 2025-08-04 | 2025-07-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +34.8K | 474.5K | +8% | — |
| D | 2025-07-22 | 2025-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +13.8K | 439.7K | +3% | — |
| D | 2025-05-02 | 2025-04-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +34.8K | 426.0K | +9% | — |
| D | 2025-04-22 | 2025-04-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +13.8K | 391.2K | +4% | — |
| D | 2025-04-03 | 2025-04-03 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +62.5K | 377.4K | +20% | — |
| D | 2025-01-22 | 2025-01-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +13.8K | 314.9K | +5% | — |
| D | 2024-10-21 | 2024-10-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +13.8K | 290.4K | +5% | — |
| D | 2024-07-22 | 2024-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +13.8K | 276.6K | +5% | — |
| D | 2024-04-19 | 2024-04-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +13.8K | 262.8K | +6% | — |
| D | 2024-04-05 | 2024-04-03 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | M - OptEx | — | +62.5K | 249.0K | +34% | — |
| 2023-11-17 | 2023-11-16 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | P - Purchase | $0.92 | +150.0K | 186.5K | +411% | +$138.0K | |
| 2023-08-24 | 2023-08-22 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | F - Tax | $1.65 | -692 | 36.5K | -2% | -$1,142 | |
| 2023-05-24 | 2023-05-22 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Collard Craig A | CEO, Dir | F - Tax | $1.45 | -691 | 37.2K | -2% | -$1,002 |
Purchase Sale Sale after option exercise All abbreviations